ASC

Quantum Announces Delayed Form 10-Q Filing for Quarter Ending December 31, 2023

Retrieved on: 
Wednesday, February 14, 2024
Software, Technology, Audio, Video, Other Technology, Late, Materiality, ASC, Accounting Standards Codification, Listing, Quantum, File, Quantum Corporation, Stand-alone, Corporation, Cryptocurrency

Quantum Corporation (NASDAQ: QMCO) (“Quantum or the “Company”) announced today that it has filed a Form 12b-25 Notification of Late Filing for the quarter ended December 31, 2023 (the “Form 10-Q”) by February 9, 2024, the original due date for such filing.

Key Points: 
  • Quantum Corporation (NASDAQ: QMCO) (“Quantum or the “Company”) announced today that it has filed a Form 12b-25 Notification of Late Filing for the quarter ended December 31, 2023 (the “Form 10-Q”) by February 9, 2024, the original due date for such filing.
  • Nasdaq previously granted Quantum an extension to regain compliance with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023 by May 7, 2024, to satisfy Nasdaq listing rules.
  • Quantum is providing its cash and long-term debt balances as of December 31, 2023, which are unaudited below.
  • Total interest expense for the three-month period ended December 31, 2023 was $3.9 million, compared to $2.7 million for the same period a year ago.

Maxx Orthopedics announces strategic partnership with THINK Surgical

Retrieved on: 
Wednesday, February 14, 2024
ASC, Orthopedic surgery, Surgeon, Patient, Partnership, Medical device

NORRISTOWN, Pa., Feb. 14, 2024 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc. (Norristown, PA.), a rapidly expanding global orthopedics device company, today announces a strategic partnership with THINK Surgical, Inc. (Fremont, CA), an innovator in the field of orthopedic surgical robots.

Key Points: 
  • Maxx Orthopedics, Inc. (Norristown, PA.), a rapidly expanding global orthopedics device company, today announces a strategic partnership with THINK Surgical, Inc. (Fremont, CA), an innovator in the field of orthopedic surgical robots.
  • NORRISTOWN, Pa., Feb. 14, 2024 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc. (Norristown, PA.), a rapidly expanding global orthopedics device company, today announces a strategic partnership with THINK Surgical, Inc. (Fremont, CA), an innovator in the field of orthopedic surgical robots.
  • Through collaboration between Maxx Orthopedics and THINK Surgical, a robotically enabled solution for the Freedom® Knee System will be developed.
  • "We are excited to enter a strategic partnership with THINK Surgical.

LeaseCrunch Announces “Lease Accounting 101: Back to ASC 842 Basics” Webinar

Retrieved on: 
Wednesday, February 14, 2024
ASC, CPA, Organization, CST

MILWAUKEE, Feb. 14, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC , a leading accounting software company, today announces the company is offering a webinar on “Lease Accounting 101: Back to ASC 842 Basics.” The webinar is tailored for CPA firm staff, accounting professionals, financial analysts and business owners seeking clarity in lease accounting and will take place on February 21 at 1:00 pm CST.

Key Points: 
  • MILWAUKEE, Feb. 14, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC , a leading accounting software company, today announces the company is offering a webinar on “Lease Accounting 101: Back to ASC 842 Basics.” The webinar is tailored for CPA firm staff, accounting professionals, financial analysts and business owners seeking clarity in lease accounting and will take place on February 21 at 1:00 pm CST.
  • The webinar will be presented by Jess Vento, senior director of accounting at LeaseCrunch and will provide essential information and insights including:
    An understanding of lease classification, terms, payment intricacies and discount rate applications.
  • “ASC 842 has had a significant impact on organizations and we understand that there are still many questions regarding the essential aspects of the standard,” states Vento.
  • “This webinar aims to provide guidance and insights on how organizations can ensure compliance and streamline their accounting practices.”
    To reserve your spot for this webinar, please visit https://www.leasecrunch.com/lease-accounting-101-reg .

ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases

Retrieved on: 
Wednesday, February 14, 2024
Inflammasome, PD, NLRC4, ALS, ASC, Inflammation, Traumatic brain injury, Nature Reviews Neurology, Neurology, Extracellular space, Neuropathology, Stroke, TBI, NLRP1, Multiple sclerosis, Intellectual disability, Therapy, Super Meat Boy, DSM-IV codes, Epilepsy, AIM2, Brain, Pharmaceutical industry

The review article summarizes data demonstrating that inflammation resulting from activation of more than one type of inflammasome contributes to development of neurological diseases and that ASC specks lead to their progression.

Key Points: 
  • The review article summarizes data demonstrating that inflammation resulting from activation of more than one type of inflammasome contributes to development of neurological diseases and that ASC specks lead to their progression.
  • ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome ASC and ASC specks from multiple types of inflammasomes to block initiation and perpetuation of damaging inflammation.
  • (Nasdaq: ZVSA or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, highlights data from a review article published in Nature Reviews Neurology.
  • The authors concluded, “Use of inflammasome-targeted therapeutic approaches could improve existing therapeutic strategies for multiple neurological conditions.” To review the publication, Click Here .

Leading LNG, LPG, Crude & Product Tanker Shipping Companies Participating at Capital Link’s 18th Annual International Shipping Forum

Retrieved on: 
Tuesday, February 13, 2024
CFO, ASC, Marketing, CPLP, Forum, FLNG, STNG, FLEX, Financial services

It is a meeting place for C-level Executives from the maritime industry and the finance and investment communities involved with shipping.

Key Points: 
  • It is a meeting place for C-level Executives from the maritime industry and the finance and investment communities involved with shipping.
  • The Forum will examine the macroeconomic issues that are shaping and transforming the international shipping markets today, featuring a comprehensive review and outlook of the various shipping markets, made more relevant by the release of companies’ annual results.
  • Discussions will include topics of critical relevance to the industry geopolitics, energy security, sanctions, access to capital, regulation, technology, innovation and more.
  • The Forum features a series of panel discussions as well as 1x1 meetings between investors and executives from shipping companies.

NetSuite Named a Leader in IDC MarketScape Report for Midmarket Finance and Accounting Applications

Retrieved on: 
Tuesday, February 13, 2024
Cloud, SOX, Oracle, Artificial intelligence, ASC, Agility, Growth, GAAP, NetSuite, Software as a service, Tax, Machine learning, IDC, Financial management

AUSTIN, Texas, Feb. 13, 2024 /PRNewswire/ -- Oracle NetSuite today announced NetSuite has been named a Leader in the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Midmarket Finance and Accounting Applications 2023–2024 Vendor Assessment (doc #US51405023, December 2023) for its two pronged approach to industries and industry specialization. A complimentary copy of the excerpt is available here.

Key Points: 
  • AUSTIN, Texas, Feb. 13, 2024 /PRNewswire/ -- Oracle NetSuite today announced NetSuite has been named a Leader in the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Midmarket Finance and Accounting Applications 2023–2024 Vendor Assessment (doc #US51405023, December 2023) for its two pronged approach to industries and industry specialization.
  • The IDC MarketScape report analyzed the functional capabilities and go-to-market strategies of finance and accounting application vendors.
  • "NetSuite is a Leader in the midmarket finance and accounting applications IDC MarketScape.
  • In addition to this report, NetSuite was also recognized as a Leader in the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Small Business Finance and Accounting Applications 2023–2024 Vendor Assessment (doc #US48041222, December 2023).

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Retrieved on: 
Tuesday, February 13, 2024
Software, Shoulder, ASC, Materialise NV, Partnership, 3D, Surgeon, Patient, SNN, Columbia University, Elective surgery, Sterilization, Sports medicine, Environment, American Academy, Medical device

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty.
  • “I’m thrilled with the stem fixation of the implant that the AETOS Shoulder System provides and believe it will be a noticeable, positive improvement for my patients,” said Dr. Matthew Ramsey, Shoulder and Elbow Specialist at Rothman Orthopaedics.
  • It is the latest addition to Smith+Nephew’s expanding Upper Extremity portfolio and complements our market-leading Sports Medicine shoulder repair solutions to enable biological healing.
  • To learn more please visit www.smith-nephew.com/aetos or visit the Smith+Nephew booth (#5469) at the American Academy of Orthopaedic Surgeons 2024 Annual Meeting from February 12-16 in San Francisco, CA.

OnPoint to participate in the 2024 Canaccord Genuity Musculoskeletal Conference

Retrieved on: 
Monday, February 12, 2024
CFO, Hospital, Congress of Neurological Surgeons, Spine, ASC, MD, Surgeon, Conference, Environment & Energy Publishing, Congress

BOSTON, Feb. 12, 2024 /PRNewswire/ -- OnPoint, a group of privately held augmented reality (AR) technology companies pioneering AR guidance for multiple verticals including spine, neurosurgical, and orthopedic surgical procedures, including robotic procedures, today announced that it will participate in the 2024 Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024, at the Westin St. Francis Hotel, San Francisco, CA.

Key Points: 
  • BOSTON, Feb. 12, 2024 /PRNewswire/ -- OnPoint, a group of privately held augmented reality (AR) technology companies pioneering AR guidance for multiple verticals including spine, neurosurgical, and orthopedic surgical procedures, including robotic procedures, today announced that it will participate in the 2024 Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024, at the Westin St. Francis Hotel, San Francisco, CA.
  • OnPoint Surgical is revolutionizing spinal procedures with the OnPoint AR Spine System which superimposes virtual surgical guides and virtual implants onto the surgeon's visual field using proprietary see-through optical head-mounted display technology.
  • The OnPoint AR Spine System platform technology is a cost-effective and highly accurate alternative to current robotic systems.
  • "OnPoint offers an attractive financial profile for hospitals and ASC's using its rapidly accretive, exceptionally accurate and cost-effective technology.

Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

Retrieved on: 
Monday, February 12, 2024
ASC, Shoulder, Zimmer Biomet, Rotation, Surgeon, Standard of care, ROSA, Fatigue, Outpatient surgery, Knee, Robotics, AAOS, Tibia, American Academy

WARSAW, Ind., Feb. 12, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is showcasing the latest innovations across its product portfolio at the 2024 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) this week in San Francisco. During the meeting, the company will display its forthcoming ROSA® Robotics application for shoulder replacement,* which is pending 510(k) clearance, and provide hands-on demonstrations of key growth drivers including Persona® OsseoTi® Keel Tibia for cementless knee replacement, ROSA® Robotics (ROSA Knee and ROSA Hip), Ambulatory Surgery Center (ASC) Solutions, as well as recently launched surgical tools including HAMMR™ Automatic Hip Impaction System, and the ViVi® Surgical Helmet System.

Key Points: 
  • "Every year, the annual AAOS meeting gives us an opportunity to not only demonstrate the breadth and diversity of our portfolio, but also shine a spotlight on the bold and meaningful innovations that transform clinical care, improve the surgical experience, and give us a differentiated competitive advantage," said Mark Bezjak, President of the Americas at Zimmer Biomet.
  • ZBEdge™ Dynamic Intelligence™ : Elevates and unlocks the full potential of Zimmer Biomet's cutting-edge digital, robotic and implant solutions.
  • In addition, the company will provide updates on its ASC strategy, partnerships and comprehensive portfolio.
  • For more information about Zimmer Biomet events at AAOS 2024, visit http://www.zimmerbiomet.com/academy2024 .

BON SECOURS MERCY HEALTH AND COMPASS SURGICAL PARTNERS TO OPEN STATE-OF-THE-ART OUTPATIENT SURGERY CENTER IN SPRINGFIELD, OHIO

Retrieved on: 
Wednesday, February 7, 2024
Partnership, BSN, Certification, Physician, Gastroenterology, Hospital, Patient, OB/GYN, General surgery, Podiatry, Bon, Abdominal ultrasonography, Elective surgery, ASC, Quality of life, Accreditation, Neurosurgery, Health, D.O, RN, Mercy Health, Operating

SPRINGFIELD, Ohio and RALEIGH, N.C., Feb. 7, 2024 /PRNewswire/ -- Springfield Regional Outpatient Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass), and local physicians, today announced the opening of its new 12,000-square-foot ambulatory surgery center (ASC) in Springfield, Ohio.

Key Points: 
  • SPRINGFIELD, Ohio and RALEIGH, N.C., Feb. 7, 2024 /PRNewswire/ -- Springfield Regional Outpatient Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass), and local physicians, today announced the opening of its new 12,000-square-foot ambulatory surgery center (ASC) in Springfield, Ohio.
  • Located at 2610 North Limestone Street, Springfield Regional Outpatient Surgery Center will offer procedures across a host of specialties, including neurosurgery, orthopedics, podiatry, plastic surgery, interventional pain management, OB/GYN, gastroenterology and general surgery.
  • "Compass is thrilled to partner with Mercy Health to establish and operate the Springfield Regional Outpatient Surgery Center, which will provide top-notch care in a comfortable outpatient setting," added Scott Bergman, Market President at Compass Surgical Partners.
  • Springfield Regional Outpatient Surgery Center is seeking accreditation from the Accreditation Association for Ambulatory Health Care and certification from Medicare.